Simplex Trading, LLC Onconova Therapeutics, Inc. Transaction History

Simplex Trading, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	BUY	$0.57 - $1.0 $894 - $1,569	1,569 New	1,569 $0
Q3 2023 Nov 01, 2023	BUY	$0.71 - $1.15 $75 - $123	107 New	107 $0
Q4 2022 Feb 02, 2023	BUY	$0.63 - $0.97 $63 - $97	100 Added 3.3%	3,127 $2,000
Q2 2022 Aug 03, 2022	SELL	$1.04 - $1.9 $1,555 - $2,842	-1,496 Reduced 33.08%	3,027 $3,000
Q1 2022 May 02, 2022	SELL	$1.46 - $2.82 $8,967 - $17,320	-6,142 Reduced 57.59%	4,523 $8,000
Q4 2021 Feb 23, 2022	BUY	$2.49 - $3.73 $26,555 - $39,780	10,665 New	10,665 $27,000

249K

Ticker ONTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,895,600
Market Cap $12.3M
Description
Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer. It has two clinical-stage programs, including narazaciclib (ON 123300), a multi-targeted kinase inhibitor that is in Phase I study for solid tumors, as well as hematological malignancies as a single agent...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.